PDF icon Download PDF
Thromb Haemost 1994; 71(05): 593-595
DOI: 10.1055/s-0038-1642488
Review Article
Schattauer GmbH Stuttgart

Fibrinogen Plasma Levels as a Marker of Thrombin Activation: New Insights on the Role of Fibrinogen as a Cardiovascular Risk Factor

Antonio Ceriello
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Mario Pirisi
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Roberta Giacomello
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Giuliana Stel
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Edmondo Falleti
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Enrico Motz
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Sebastiano Lizzio
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Fabio Gonano
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
,
Ettore Bartoli
The Department of Clinic and Experimental Pathology, Chair of Internal Medicine and Chair of Clinic Pathology, University of Udine, Udine, Italy
› Author Affiliations
Further Information

Publication History

Received 02 September 1993

Accepted after revision 31 January 1994

Publication Date:
06 July 2018 (online)

 PDF Download  Permissions and Reprints
Preview

Summary

Fibrinogen has recently emerged as a major risk factor for athero- thrombosis. However, the pathophysiologic mechanism linking high fibrinogen concentration to cardiovascular disease is unclear.

In this study 136 subjects (75 males, 61 females, age 51.7 ± 14.4 years, mean ± standard deviation, range 17-82) were tested for total and HDL-cholesterol, total triglycerides, apolipoprotein AI, apolipo- protein B, fibrinogen, prothrombin fragment and D-dimer. Moreover, 5 subjects who had hyperfibrinogenemia (range 450 to 950 mg/dl) for at least 6 months by repeated measurements, were treated with a short 7-day course of heparin 12,500 U/day subcutaneously. The effect of heparin on all the above mentioned parameters was observed at the end of treatment and after 7 days of wash-out. Simple regression analysis detected a positive correlation between fibrinogen and age, prothrombin fragment and D-dimer, and a negative correlation between fibrinogen and HDL-cholesterol and apolipoprotein AI. A direct correlation between age and both prothrombin fragment and D-dimer was also demonstrated. Multivariate analysis showed a persistent correlation between fibrinogen and prothrombin fragment, D-dimer and age, that was not influenced by sex, smoking habit and body mass index. In the 5 hyperfibrinogenemic subjects, heparin administration significantly reduced fibrinogen (625.4 ± 211.1 vs 455.2 ± 112.3 mg/dl, p <0.03), prothrombin fragment (0.97 ± 0.1 vs 0.63 ± 0.2 nM, p <0.002) and D-dimer (336 ± 101.8 vs 275.2 ± 78.5 ng/ml, p <0.03). All these parameters returned to baseline after 7 days of wash-out (fibrinogen 632.5 ± 198.2 mg/dl, prothrombin fragment 0.96 ± 0.2 nM, D-dimer 325.8 ±98.65 ng/ml).

These data indicate that fibrinogen plasma levels are strongly correlated to parameters of thrombin activation in plasma and suggest that high fibrinogen plasma levels might be a risk marker for cardiovascular disease because expression of an existing thrombophilia.